Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2714)	3/19/2010 1:01:27 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CLDX was up 10.91% at its intraday H and is still up 7.66% at present with volume of >1.35M about 3.5x its ADV The stock traded earlier today above its Oct H <g> bigcharts.marketwatch.com The stock is having some help from the presentation this week at the 22nd Annual Roth Capital OC Growth Stock Conference at the Ritz-Carlton,in Laguna Miguel, CA. CLDX drug candidates are antibody-based and it has eight products in its pipeline mainly focused on the treatment of several cancers. The ACTAY is $11.25 and it seems that with some good news it could get to test the resistance at the $10 level.<g> bigcharts.marketwatch.com Bernard